Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

No 4 (2019)

Articles

pages 6-8 views

3D-TECHNOLOGIES IN PLANNING AND NAVIGATION FOR LAPAROSCOPIC INTERVENTIONS IN PATIENTS WITH RENAL AND URETERIC STONES

Alyaev Y.G., Sirota E.S., Bezrukov E.A., Ali S.H.

Abstract

Aim: to evaluate the possibilities and efficiency of using 3D technologies for the laparoscopic interventions in patients with renal and ureteric stones. Materials and methods. A retrospective analysis of the results of surgical treatment of patients with renal and ureteric stones performed in the urology clinic of the I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia for the period from January 2012 to December 2017 was carried out. During this period a total of 4958 interventions were done. Among them, 98 laparoscopic (1.97%) surgeries were performed, including nephron-sparing interventions (n=47; 48%), pyelolithotomy (n=15; 15.3%), ureterolithotomy (n=32; 32.65%) and partial nephrectomy (n=4; 4.05 %). The average patients’ age was 55.76±10.5 (29-80) years. There were 51 men (52%) and 47 women (48%). The mean stone density was 1237.6±354.6 HU (from 500 to 1913 HU). In 14 (22.9%) cases, nephrostomy tube or ureteric stent had been put before surgery. In addition, 40 (40.8%) patients previously underwent one surgical intervention on the kidneys and 17 patients with urinary stone disease (17.3%) underwent surgery ≥ 2 times. 88 (89.8%) patients had severe concomitant diseases and the most common pathology in 51 (52.0%) patients with urinary stone disease was arterial hypertension. In 11 (11.2%) cases, the interventions were performed in patients with abnormal kidneys, including horseshoe kidney (n=6; 6.1%), duplicated collecting system (n=3; 3.1%) and pelvic kidney (n=2; 2%). In addition to standard preoperative diagnostic methods in 22 cases (22.4%) the 3D-planning and multivariate virtual performing of intervention based on the multidetector computer tomography scan was done using Amira 3D-modeling program. Among these patients, virtual interventions were performed prior to all pyelolithotomy and partial nephrectomy. Intraoperative data of virtual constructions were used by surgeons as navigation. The interventions were performed by seven urologists at the clinic with various experience in laparoscopic surgery. Results. The mean duration of laparoscopic pyelolithotomy, laparoscopic partial nephrectomy, laparoscopic ureterolithotomy and laparoscopic nephrectomy was 183.2±69.6, 201.3±35.2 min, 97.6±43.7 and 165.4±92.3 min, respectively. The minimal blood loss was observed during laparoscopic ureterolithotomy (53.33+31.2 ml). During these interventions, in 8 cases (8.16%) a flexible endoscope was used for inspection and complete removal of stones. Intraoperative complications were noted in 6 patients (6.1%). There were 4 conversions to open surgery (4.1%). Postoperative surgical complications were observed in 1 (1%) patient, while non-surgical complications developed in 4 patients (4.1%). There was no mortality. Conclusion. Laparoscopic access for the treatment of patients with urinary stone disease should be used for the treatment of patients with large, long-standing ureteral calculi and patients with kidney stones who have concomitant pathology of kidney or upper urinary tract (UPJ obstruction, kidney tumors) requiring surgical intervention. Laparoscopic access should be considered primarily for the planning of laparoscopic partial nephrectomy and laparoscopic nephrectomy in patients with urinary stone disease. The use of 3D computer-assisted technologies is advisable for patients with urinary stone disease and abnormal kidneys if laparoscopic pyelolithotomy, partial nephrectomy or ureterolithotomy is planned
Urologiia. 2019;(4):9-15
pages 9-15 views

LAPAROSCOPIC PYELOPLASTY IN RECURRENT URETEROPELVIC JUNCTION OBSTRUCTION

Guliev B.G.

Abstract

Performed more commonly and in case of its failure a repeated pyeloplasty can be done. The aim of the study was to assess the results of laparoscopic pyeloplasty in these recurrent cases. Materials and methods. A total of 178 laparoscopic pyeloplasty was performed in urologic clinic from February 2010 to March 2018. In 18 patients (10.1%), including 11 men and 7 women, recurrent UPJ obstruction was diagnosed. Mean age was 36.5±8.0 years. There were 12 left UPJ obstruction and 6 right UPJ obstruction. Previously, 10 and 8 patients undergone open and laparoscopic pyeloplasty, respectively. Retrograde pyelothomy was done in 12 cases (75.0%). All patients had clinical symptoms and obstructive curve pattern on dynamic scintigraphy. Intra- and postoperative complications were graded using Clavien classification. The results of laparoscopic pyeloplasty were evaluated by excretory urography and dynamic scintigraphy. Results. There was no conversion. Mean duration of laparoscopic pyeloplasty was 105.5±28 min. The surgery was more prolonged in patients who previously undergone transperitoneal laparoscopic pyeloplasty. Conversely, laparoscopic pyeloplasty after failed open retroperitoneal pyeloplasty was less complicated. Mean blood loss was 60.0±20.5 ml. There was no intraoperative complications and postoperative complications developed in 3 patients (16.7%), including fever in 2 cases (grade II on Clavien) and urinary leakage in 1 patient (grade I on Clavien). Laparoscopic pyeloplasty was ineffective in 1 case (5.4%), according to dynamic scintigraphy. Conclusion. Laparoscopic pyeloplasty is feasible method in case of recurrent UPJ obstruction despite scar tissue in the area of intervention.
Urologiia. 2019;(4):16-19
pages 16-19 views

EXPERIENCE OF USING THE ANTIBACTERIAL DRUG FOSFOMYCIN ESPARMA FOR THE TREATMENT OF ACUTE UNCOMPLICATED CYSTITIS IN WOMEN

Aboyan I.A., Orlov Y.N., Voloshina O.A., Orlov N.V., Pavlov D.S.

Abstract

Aim. To evaluate the efficacy and safety of the antibacterial drug fosfomycin trometamol (Fosfomycin Esparma) in women of reproductive age with acute uncomplicated cystitis. Materials and methods. In order to assess the efficacy and safety of using fosfomycin trometamol (Fosfomycin Esparma), a prospective, non-randomized, uncontrolled study involving 32 women with acute uncomplicated cystitis was carried out. The average patients’ age was 27.3±3.1 years. Before the study, all women underwent a general clinical, bacteriological, and ultrasound examination. Inclusion criteria was the presence of pathognomonic symptoms of acute uncomplicated cystitis. Exclusion criteria were as following: complicated urinary tract infection, anatomical and functional disorders of the urinary tract, comorbidities. All patients were prescribed a study drug at a dose of 3 g, once. The efficiency of therapy was evaluated on days 3 and 14 after administration of Fosfomycin Esparma based on clinical and microbiological cure and safety. Results. The only bacterial pathogen isolated from the urine was E. coli. In 4 cases (12.5%) strains produced extended-spectrum β-lactamase. The sensitivity of E. coli to fosfomycin, piperacilfin/tazobactam, amikacin and meropenem was 100%. A resistance to ampicillin was 15.6%, compared to 9.4% for levofloxacin and norfloxacin and 12% for cefotaxime, ceftazidime, cefpoxin. By the 3rd day after receiving fosfomycin, the symptoms of cystitis were resolved in all patients. On day 14, according to the results of the urine culture, there was no growth of bacteria. During the follow-up period, no significant side effects was detected. Conclusion. Our study showed that antibacterial drug Fosfomycin Esparma in women of reproductive age with acute uncomplicated cystitis is effective and safe. Maintaining a high sensitivity to fosfomycin allows us to recommend this drug as an empirical antibiotic therapy in this cohort of patients.
Urologiia. 2019;(4):20-25
pages 20-25 views

INLUENCE OF OSTEOPOROSIS AND ITS CAUSATIVE FACTORS ON THE PREVENTION OF RECURRENCE OF URINARY STONE DISEASE

Demidko L.S., Rudenko V.I., Fadeev V.V., Demidko Y.L., Amosov A.V., Kuz’micheva G.M., Grigoryan V.A., Enikeev M.E., Amosova M.V.

Abstract

Introduction. The aim of postoperative examination, treatment and follow-up of patients with urinary stone disease is a prevention of recurrence. A choice of method of prevention is based on the results of postoperative examination with consideration of etiological factors of urinary stone disease. An analysis of influence of osteoporosis and its causative factors on the recurrence of urinary stone disease is presented in the article. Aim: to clarify the influence of osteoporosis and its causative factors on excretion of calcium, uric acid and recurrence of urinary stone disease. Materials and methods. A total of 86 patients after surgical treatment of urinary stone disease were included in the study. A physicochemical analysis of stones and their fragments, excretion of calcium and uric acid were done postoperatively. The risk factors for osteoporosis were identified using specific questionnaire. Bone mineral density (BMD) was assessed by X-ray densitometry. After X-ray phasic analysis of the stones and studying of the daily excretion of calcium and uric acid, 10 and 7 patients were prescribed to thiazide diuretics and allopurinol, respectively. In 69 patients (80.2%) there were no indications to the treatment and all of them were included in control surveillance group. Results. Calcium oxalate stones were predominated in patients who were under surveillance (p=0,0254). A prevalence of risk factors for osteoporosis was similar in all groups (р=0,2156), as well as rate of decrease in BMD (р=0,64). In patients taking thiazide diuretics, a significant decrease in daily calcium excretion was found (р=0,0054) without significant changes in excretion of uric acid and diuresis volume. Among patients receiving allopurinol there was a significant decrease in daily uric acid excretion (р=0,021), without significant changes in excretion of calcium and diuresis volume. There were no significant changes of these values in the control group. A recurrence of urinary stone disease in treatment group was detected in 4 patients with a decrease of BMD after 381±61 days, while in control group there were 5 recurrences in patients with decreased BMD and I recurrence in patient with normal BMD after 836±64 days. Conclusion. Treatment aimed at prevention of recurrence of urinary stone disease allows to correct detected metabolic disturbances. However, such factor as the decrease in BMD can influence on the rate and frequency of recurrence of urinary stone disease. A clarifying of risk factors for osteoporosis and diagnosis of osteoporosis allow to give reliable recommendations for its treatment and to decrease risk of recurrence of urinary stone disease.
Urologiia. 2019;(4):26-31
pages 26-31 views

EXPERIMENTAL MORPHOLOGICAL RATIONALE FOR THE USE OF MULTIPOTENT MESENCHYMAL STEM CELLS CULTURES IN COMBINATION WITH BIOMATERIALS FOR THE RECONSTRUCTION OF THE PELVIC FLOOR

Pavlov V.N., Yashchuk A.G., Musin I.I., Mufazalova N.A., Shangina O.R., Fatkullina I.B., Danilko K.V., Kulavskiy V.A., Mehtieva E.R., Molokanova A.R.

Abstract

To date, descension of the pelvic floor is a fairly common gynecological pathology that requires surgical treatment. The development of cellular technologies suggests that the use of multipotent mesenchymal stem cells (MMSC) in the treatment of this pathology can stimulate the regeneration of damaged tissue and contribute to the reconstruction of the structures of the pelvic floor. Objective: to evaluate the effectiveness of using MMSC in combination with biological and synthetic materials in vitro and in vivo with descension of the pelvic floor. Materials and methods: Sprague Dawley rats 10 weeks old weighing 200 grams were used in the experiment. Under sterile conditions, mechanical damage to the posterior wall of the vagina was carried out, with the restoration of which vicryl 3-0 was used. On the 2nd and 4th day, the wound was cut off in a volume of 1.5 ml with xenograft, allograft and multipotent mesenchymal stem cells (MMSC) (5 thousand cells) obtained from the adipose tissue of rats. In the control group was not used biological material. At the second stage of the experiment, the compatibility of the mesh prosthesis with MMSC and allograft in vitro was evaluated. Results and discussion: xenograft does not lead to full tissue regeneration, but contributes to rapid epithelialization and reduces the degree of inflammatory reaction in the wound during the regeneration of connective tissue. The use of allograft leads to quick and complete epithelialization of the wound and the formation of a structurally complete connective tissue lamina of the vaginal mucosa. The introduction of MMSC resulted in complete epithelialization of the wound and the formation of a structurally complete connective tissue plate of the mucosa and submucosa, but with a slightly smaller number of blood vessels in them than with the use of a biomaterial. At the second stage of the experiment, weak cell adhesion to the polypropylene substrate of the tablet was observed during cell culture in the presence of only a fragment of the mesh prosthesis. After MMSC cultivation in the presence of a mesh prosthesis fragment and an allograft, a relatively uniform distribution of cells around the mesh prosthesis loops was observed. Conclusions: it was determined that the use of MMSC and allograft has a positive effect on the process of vaginal tissue regeneration in rats. When combining these materials with mesh prostheses, it was found that MMSCs are not fixed directly to the synthetic material, but when the allograft is added, they concentrate and presumably have the maximum anti-inflammatory effect and promote tissue regeneration at the site of the mesh prosthesis. Thus, the use of autologous MMSC cells in combination with allograft and mesh polymeric materials for pelvic floor reconstruction can significantly improve the results of reconstructive operations.
Urologiia. 2019;(4):32-37
pages 32-37 views

PREVENTION OF BLEEDING DURING TUBELESS PERCUTANEOUS NEPHROLITHOTOMY

Merinov D.S., Gurbanov S.S., Artemov A.V., Arustamov L.D., Epishov V.A.

Abstract

Introduction. Nephrostomy tube placed after percutaneous removal of kidney stones can cause pain and discomfort in the early postoperative period [1, 2]. A tubeless percutaneous nephrolithotomy (PCNL) is considered as alternative approach. However, the most serious complication after tubeless procedure is a development of active uncontrolled bleeding from percutaneous tract in the early postoperative period. Aim. To improve the results of surgical treatment of kidney stones by evaluation of efficiency of using hemostatic matrix during tubeless PCNL. Materials and methods. A total of 113 patients with large kidney stones undergone to the tubeless PCNL for the past 9 years in our clinic. The external or internal stent was put for the drainage of upper urinary tract for 2 and 14 days, respectively. All patients were divided into 2 groups, depending on severity of bleeding (group 1 - no bleeding vs. group 2 - mild bleeding). Each group was further divided into two subgroups based on the technique and type of drainage of upper urinary tract at the end of the surgery. In the main group (n=74) the hemostatic matrix based on lyophilized thrombin 2000 IU was injected in percutaneous tract at the end of the surgery. The control group included 39 patients who underwent mini-PCNL without using hemostatic matrix. The blood loss, intensity of urine leakage from percutaneous tract (duration, visual analog scale) and degree of fluid extravasation in pararenal fat estimated by US were evaluated. Results. The mean operative time was 47.5±3.6 min (52, 58, 38 and 49 min in subgroup I, II, III and control group, respectively). Hemoglobin drop was 9.3±4.1, 12.1±7.5, 14.6±11.2 and 10.6±5.9 in subgroups I, II, III and in the control group, respectively, while duration of hematuria was 16.1, 20.3, 28.5 and 22.9 hours, respectively. Fluid extravasation in pararenal space was found in 1 out 7 patients in subgroup III and control group, respectively (p<0.05). The dilatation of collection system (after double-J) persisted in 18.1%, 20% 22.2% and 13.3% cases in subgroup I, II, III and control group, respectively. There were no significant differences in other evaluated parameters. In 1 case in the control group there was severe bleeding which required selective embolization of the renal artery. Conclusion. The use of hemostatic matrix is an additional important measure which allows to prevent active bleeding from the percutaneous tract in early postoperative period. Moreover, the hemostatic matrix contributes to the sealing of tract and reduces the risk of fluid extravasation in pararenal space after mini-PCNL.
Urologiia. 2019;(4):38-43
pages 38-43 views

RADICAL CYSTECTOMY: THERAPEUTIC ASPECTS OF PREOPERATIVE AND EARLY POSTOPERATIVE MANAGEMENT

Darenkov S.P., Pinchuk I.S., Proskokov A.A., Trofimchuk A.D., Fedulaev Y.N., Pinchuk T.V., Makarova I.V., Andreeva O.N.

Abstract

Aim: to improve the results of radical cystectomy by optimization of patient preparation for surgery and early postoperative care. Materials and methods. A total of 136 patients who underwent radical cystectomy and either orthotopic ileal neobladder or ileal conduit formation were included in the study. Brikker’s operation was performed in 92 patients (76% men and 24% women) aged from 39 to 83 years, while in 44 patients (97.7% men, 2.3% women) aged from 32 to 75 years the Studer ileal neobladder was created. All patients underwent preoperative comprehensive examinations in order to determine type and extent of surgical treatment. Results: A complication rate after radical cystectomy with urine derivation using bowel segment was 49.2%. Mortality rate in early postoperative period was 3.9%. Conclusion: An algorithm of postoperative care after radical cystectomy with formation of either orthotopic neobladder or ileal conduit and consideration of comorbid status and preparation which we have used in clinical practice was developed. According to the results, after implementation of algorithm of management in preoperative and early postoperative period a decrease in complications and mortality rate has been found.
Urologiia. 2019;(4):44-50
pages 44-50 views

IMPACT OF PD-L1 STATUS ON THE LONG-TERM OUTCOMES OF RADICAL TREATMENT OF PATIENTS WITH PROSTATE CANCER

Matveev V.B., Kirichek A.A., Safronova V.M., Khafizov K.O., Filippova M.G., Lyubchenko L.N.

Abstract

A wide range of variables are associated with poor long-term outcomes of radical treatment in patients with prostate cancer (PCa). Expression of the programmed death-1 ligand 1 (PD-L1) in tumor might be a potential novel marker for PCa. Aim: to evaluate the influence of PD-L1 expression status in tumor cells on long-term results of radical treatment in patients with PCa. Materials and methods: a total of 45 patients with pathologically-proven PCa who undergone radical treatment and followed at N.N. Blokhin National Medical Research Center of Oncology were retrospectively analyzed. In all cases PD-L1 expression in tumor cells was evaluated by immunohistochemical studies of paraffin block sections obtained under direct control of pathologist. Positive expression of PD-L1(+) was defined as expression level in tumor cells ≥ 1%, while hyperexpression was diagnosed when expression level L1 ≥ 5%. Results: PD-L1 expression and hyperexpression in tumor cells were identified in 8 (17.8%) and 6 (13.3%) cases. Median metastasis-free survival in patients with positive PD-L1 expression was 48.918 months (95% CI 42.523-55.313) and was less than in patients with negative PD-L1 expression (68.033 months, 95% CI 48.242- 87.824, p=0.090). Cancer-specific survival in patients with negative PD-L1 expression was significantly longer compared to patients with positive expression (p=0.05) and hyperexpression (p=0.024) of PD-L1 in tumor cells. Multivariate Cox analysis confirmed independent predictive value of positive expression and hyperexpression of PD-L1 in tumor cells for metastasis-free survival (HR 3.461, 95% CI 1.171-10.228, p=0.025, and HR 3.916, 95% CI 1.129-13.591, p=0.032) and cancer-specific survival (HR 7.65, 95% CI 0.69-84.51, p=0.097, and HR 9.73, 95% CI 0.87-108.78, p=0.065). Conclusion: According to our study and published data, positive PD-L1 expression in tumor cells is associated with poor prognosis of PCa. Given the lack of association of PD-L1 expression in tumor cells with the routine clinical and pathological characteristics of the disease, it seems reasonable to include the status of PD-L1 expression in the current predictive nomograms for patients with PCa. The results may indicate the potential benefits of developing personalized approaches to PCa treatment, particularly with targeting a PD-L1/PD-1 signaling pathway in tumor cells.
Urologiia. 2019;(4):51-57
pages 51-57 views

A COMPARATIVE CHARACTERISTICS OF TREATMENT RESULTS OF PATIENS WITH BENIGN PROSTATIC HYPERPLASIA IN COMBINATION WITH HYPOGONADISM

Kamalov A.A., Vasilevskiy R.P., Okhobotov D.A., Neplokhov E.A.

Abstract

Aim: to compare the efficiency of monotherapy with α-blockers vs combined therapy (а-blockers in combination with Androgel) in patients with BPH and hypogonadism. Materials and methods: a total of 60 men with BPH and hypogonadism, who were randomly selected from outpatient department were included in the study. All patients were divided into 2 groups (n=30). In Group 1 patients received silodosin, while in Group 2 men were prescribed to silodosin plus Androgel 1% topically. The duration of therapy was 6 months. The results of treatment were evaluated during baseline assessment and further visits every 2 months after starting therapy (total 4 time points). Results: according to the ICEF-5 questionnaire, in the Group 2 an improvement in sexual function domain score (from 6.3 to 26.8 points) was shown. In addition, in combination group there were significant changes in PSA level (from 2.25 to 1.8 ng/ml), prostate volume (from 55.1 to 61.3 cm3), residual urine volume (from 72 to 19 ml), urine flow rate (from 13.34 to 21.1 ml/s), waist circumference (from 116 to 103.2 cm) and body mass index (from 35.4 to 27.2 kg/m2), while in monotherapy group none of these indicators significantly improved. Conclusions: the use of topical hormone replacement therapy in combination with α-blockers in patients with BPH and concomitant hypogonadism is justified and effective in comparison with monotherapy with α-blockers.
Urologiia. 2019;(4):58-61
pages 58-61 views

DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED STUDY OF EFFICIENCY AND SAFETY OF COMPLEX ACETYL-L-CARNITINE, L-CARNITINE FUMARATE AND ALPHA-LIPOIC ACID (SPERMACTIN® FORTE) FOR TREATMENT OF MALE INFERTILITY

Gamidov S.I., Ovchinnikov R.I., Popova A.Y.

Abstract

Introduction. Oxidative stress of sperm is a common pathologic condition, which can be detected in 30-80% infertile men. It is established that dietary consumption of antioxidants and microelements contributes to an increase of conception probability in subfertile couples, and also reduces the risk of reproductive losses. Drug complexes influencing various factors of spermatogenesis disturbance (oligo-, astheno-, teratozoospermia), oxidative stress and the level of sperm DNA fragmentation are of greatest and reasonable interest. Aim. To study the effects of complex acetyl-l-carnitine, l-carnitine fumarate and alpha-lipoic acid (SpermActin® Forte) on oxidative stress, ejaculate quality and sperm DNA fragmentation in men with infertility. Materials and methods. A total of 80 infertile men aged 25-40 years with increased level of sperm DNA fragmentation and oxidative stress were included in open-label, prospective, randomized study. In Group A (n=20) patients received a placebo for 180 days, and in Group B patients were prescribed to SpermActin® Forte, 1 sachet of 10 g once a day. The criteria for the efficiency of therapy included sperm analysis, the level of sperm DNA fragmentation, the level of sperm oxidative stress, as well as information about achievement of pregnancy, obtained by interviewing all participants. Results: In patients taking antioxidant complex SpermActin® Forte there were significant positive changes in the main parameters of sperm analysis, including sperm mobility and morphology starting from the third month of therapy. The level of free oxygen radicals (as indicator of oxidative stress) in Group B also significantly decreased (by 86%). A more profound decrease in DNA fragmentation was seen in Group B compared to Group A (21.5% vs. 3.6%). Pregnancy was achieved in 1 and 13 cases in Group A and B, respectively. Conclusion. The use of the SpermActin® Forte antioxidant complex allowed to improve sperm analysis in most patients, and these changes were significant starting from the third month of therapy. Stimulation of spermatogenesis using the antioxidant complex SpermActin® Forte is an effective and safe method of treating male infertility.
Urologiia. 2019;(4):62-68
pages 62-68 views

THE INFLUENCE OF PROTEOLYTIC ENZYMES ON THE ANTIOXIDANT DEFENSIVE SYSTEM IN INFERTILE MARRIED MEN

Neumark A.I., Neymark B.A., Nozdrachev N.A., Bryukhanov V.M., Plotnikova A.Y., Podpruzhnikova D.A., Nikulina A.A.

Abstract

The causes of male infertility remain unclear in 30-75% cases and are considered idiopathic. The study of influence of free oxygen radicals on the male reproductive function is of outmost interest. Given the important role of hyaluronidase in the penetration of sperm into the egg, we decided to evaluate the drug Longidaza, which has long-acting enzymatic (proteolytic) activity. A total of 48 men with idiopathic infertility were included in the study. All patients were divided into two groups (24 men each). In Group 1 there was a recommendation to attempt to conceive for 1 year without additional treatment. In Group 2, patients were prescribed Longidaza according to the proposed scheme. During the follow-up, there was a significant improvement in the antioxidant defense system of the ejaculate in Group 2, which was accompanied by an increase in the fertilizing ability of the ejaculate and an increase in number of conceptions by 29.1%
Urologiia. 2019;(4):69-73
pages 69-73 views

POLYAMINES OF UROGENITAL TRACT MEN AS FACTORS OF APOPTOSIS REGULATION SPERMATOZOIDS

Ploskonos M.V., Evdokimov V.V.

Abstract

The aim of the study was to compare the content of polyamines (spermine and spermidine) in the seminal plasma of men of different fertility and to reveal the relationship between their level in sperm and the presence of markers of apoptosis in gametes. Materials and methods: ejaculates of 34 fertile men and 40 infertile men with various forms of subfertility between the ages of 22 and 40 were examined. The determination of polyamines was carried out by electrophoretic fractionation in an agar gel. As markers of apoptosis, externalization of phosphatidylserine (PS) to the external side of the spermatozoon membrane was determined and the receptor for the initiation of apoptosis CD95 in the gametes was detected. Results: In sperm of infertile men, more spermatozoa with markers of apoptosis were revealed in comparison with fertile donors (p 0,001). Against the background of a general decrease in the concentration of polyamines in ejaculates of infertile patients, the ratio between polyamines with a predominance of sperm in the seminal fluid is observed, which is the initiating factor for the initiation of apoptosis in gametes. This was proved by the relationship between the externalization of FS in gametes and the concentration of sperm in the spermoplasm in accordance with the coefficient of positive correlation (r=0.5, p<0.01). Conclusions: Thus, a change in the concentration of polyamines in the seminal fluid of men is one of the factors in the regulation of apoptosis of the sex cells. Determination of the content of polyamines in seminal plasma can be recommended to increase the information content of the study of the causes of impaired fertility of the ejaculate, and the results obtained for the development of the algorithm for examining infertile patients.
Urologiia. 2019;(4):74-79
pages 74-79 views

ERECTILE FUNCTION AFTER CORPOROPLASTY IN PATIENTS WITH PEYRONIE’S DISEASE

Gamidov S.I., Popkov V.M., Shatylko T.V., Ovchinnikov R.I., Korolev A.Y., Popova A.Y., Gasanov N.G.

Abstract

Purpose. To evaluate erectile function in patients with Peyronie’s disease (PD) who underwent corporoplasty. Materials and methods. A total of 374 patients who underwent corporoplasty by a single surgeon during 1996-2016 were analyzed. In all cases IIEF questionnaire was evaluated pre- and postoperatively. Intracavernous injection test and penile doppler ultrasonography were performed if required. Median follow-up was 9.5 years. Analysis of risk factors for erectile dysfunction (ED) before and after corporoplasty was performed. Results. Prevalence of risk factors for ED in our sample has greatly increased during follow-up. At the last follow-up visit 285 patients were sexually active. Evaluation of patient satisfaction with the quality of erections has shown that 139 patients were fully satisfied (48.8%), 84 patients were somewhat satisfied (29.5%) and 62 patients were not satisfied with their erectile function (21.7%). According to IIEF questionnaire, 105 patients (36.8%) had no ED (> 26 points); 74 patients (26%) had mild ED; 67 patients (23.5%) had mild-to-moderate ED; 21 patients (7.4%) had moderate ED; and 18 patients (6.3%) had severe ED. However, a causal relationship between ED and treatment of Peyronie's disease was found not in all cases. Seven patients had infrequent sexual intercourse (1-2 per month) and 50 patients had no sexual activity. Discussion. At long term after corporoplasty some patients experience ED, though causality between ED and PD treatment couldn’t be confirmed in all such cases. It should be noted that we have found an increase in prevalence of independent risk factors for ED during follow-up period. These patients could possibly benefit in terms of quality of life if they underwent penile prosthesis placement during primary surgical treatment for PD. However, some patients had no sexual activity due to causes unrelated to ED. Conclusion. Not all patients with PD are satisfied with their sexual functioning after corporoplasty. However, ED after surgical management of PD is not always a consequence of surgery itself.
Urologiia. 2019;(4):80-84
pages 80-84 views

PREVENTION OF PERIOPERATIVE COMPLICATIONS IN CHILDREN WITH CONGENITAL UROPATHIES

Morozova O.L., Morozov D.A., Lakomova D.Y., Maltseva L.D., Morozov D.D.

Abstract

Aim. To substantiate the expediency of immunomodulators and probiotics application pathogenetically in the comprehensive preoperative preparation in children with congenital uropathies (ОТ). Materials and methods. The study includes 60 patients with various types of congenital uropathy (CU) (vesicoureteral reflux, hydronephrosis, obstructive ureterohydronephrosis), which were divided into 3 groups in accordance with the preoperative preparation complex. 1 group - 20 patients with VU, immunomodulating drug Kipferon was added to the therapy at the preoperative stage, group 2 - 20 patients with VU - with the addition of the biologically active additive (BAA) «Bifidum №791 BAG», 3 control group - 20 children with VU standard complex of preoperative preparation. The diagnosis of VU was established using a standard urological examination. The examination of the content of pro-(IL-8) and anti-inflammatory (IL-10) cytokines in the urine was performed before the start of treatment (1 point) and on the 3-5th day after surgery (2 point) for all patients using the method of enzyme-linked immunosorbent assay. Results. Based on signs of systemic inflammation and urinary syndrome, initially patients of all groups (n=60) were in the latent phase of chronic obstructive pyelonephritis. After surgical correction pyelonephritis was diagnosed in all children at point 2, the most pronounced was in the control group. Manifestation of dysbiosis in the control group was more often by 20% than in group 2. The examination of the cytokine profile of urine showed an increasing the level of IL-8 (p<0.0001) at 2 points in all groups, the most significant was in the control group (p<0.002). An increasing the level of IL-10 (p<0.0001) was noted at point 2 in all groups, the most significant was in groups 1 and 2 (p<0.003). High values of the inflammation activity index were observed only at point 2 in the children of the control group (p<0.001). Conclusion. The using of immunomodulators and probiotics in the comprehensive preoperative preparation of children with obstructive uropathies reduces the risk, severity and duration of postoperative complications.
Urologiia. 2019;(4):85-90
pages 85-90 views

EARLY CORRECTION OF HYPOSPADIAS IN GIRL WITH A DISORDER OF SEX DEVELOPMENT. CLINICAL CASE

Anikiev A.V., Kalinchenko N.Y., Volod’ko E.A., Brovan D.N., Okulov A.B., Bezlepkina O.B.

Abstract

The presented clinical case of a girl with a salt-wasting form of congenital adrenal hyperplasia in combination with chronic recurrent infection and lower urinary tract dysfunction demonstrates the need to change conventional two-staged approach to surgical feminization in favor of a one-stage intervention in order to prevent a progression of genitourinary complications. After controlling for the underlying condition, the one-stage feminization was performed, including modified tightening introitoplasty using a Passerini-Glazel flap and a correction of hypertrophic clitoris and labia minora. Good short- and long-term results were achieved.
Urologiia. 2019;(4):91-94
pages 91-94 views

PENILE PROSTHESIS IMPLANTATION THROUGH SUBCORONAL APPROACH IN PATIENTS WITH TOTAL CAVERNOUS FIBROSIS

Akhvlediani N.D., Reva I.A., Bernikov A.N., Chernushenko A.S., Pushkar D.Y.

Abstract

Penile prosthesis implantation is a treatment choice in patients with erectile dysfunction (ED) accompanied by cavernous fibrosis. Methods for creation of space for penile cylinders during prosthesis implantation in patents with total cavernous fibrosis are still under discussion, considering high risk of complications and decrease in penile size. In the presented clinical case, a new surgical technique for performing a three-piece penile prosthesis implantation through subcoronal approach in patient with ED, complicated by total cavernous fibrosis, is described. This clinical case represents our first experience of excavation excision of scar tissue in cavernous bodies through an innovative subcoronoral approach. As a result of performing of excavation excision of scar tissue in cavernous bodies, capacious spaces were created which allowed to use a three-piece prosthesis with a standard cylinder diameter. It ensured good long-term functional and cosmetic results. The first experience of excavation excision of fibrotic cavernous bodies during inflatable penile prosthesis implantation through subcoronal approach suggests its potential efficacy and safety in patients with ED and total cavernous fibrosis.
Urologiia. 2019;(4):96-100
pages 96-100 views

DIAGNOSTIC SEARCH FOR CAUSES FOR URINARY HOLDING IN A UNIFORM KIDNEY GIRL

Zorkin S.N., Turov F.O., Borisova S.A., Bespalyuk O.I., Uvarov B.N.

Abstract

Ectopic of the ureter into the cervix is a rare case in the clinical practice of pediatric urologists around the world. This paper presents an observation of congenital urinary incontinence in a 13-year-old girl who underwent an annual examination in a hospital at the place of residence.
Urologiia. 2019;(4):101-104
pages 101-104 views

NOVEL APPROACHES FOR TRANSURETHRAL EN-BLOC RESECTION OF LARGE BLADDER TUMORS

Kislyakov D.A., Severgina L.O., Tsarichenko D.G., Rapoport L.M., Korovin I.A., Sorokin N.I.

Abstract

Objective: to develop optimal techniques of en-bloc resection of large non-muscle invasive bladder tumors, determine the proper method of specimen extraction and assess the quality of specimens obtained by different techniques. Materials and methods. A total of 12 patients with primary cT1 bladder cancer underwent transurethral en-bloc resection between January 2018 and March 2019 were enrolled into the study. Tumor size ranged from 3.5 cm to 6.2 cm. For removal and extraction of large bladder tumors using thulium fiber en-bloc laser three different techniques were developed: “swiss cheese technique”, “crown and root technique” and “three steps technique” technique». The main pathologic criteria used for assessment of removal technique were tumor grade (G), depth of invasion (T), presence of carcinoma in situ (CIS), variant histology (VH), lymphovascular invasion (LVI), presence of detrusor muscle. Additional criteria were horizontal and vertical resection margin, subclassification of T1-stage and presence of focal necrosis in tumor. Results. Among the techniques developed and tested, the best quality of specimens for morphological evaluation was obtained using the combined «crown and root technique». First step is electroresection of the exophytic part of the tumor into pieces, and the next step is en-bloc laser resection (using thulium fiber or holmium laser) of the tumor base. Overall, the quality of all specimens obtained using three techniques met the current requirements of pathologic study. Summary. En-bloc resection techniques of large bladder tumors allow obtaining specimen suitable for proper morphological evaluation and correct tumor staging. Further studies are required to evaluate the impact of these techniques on long-term results of treatment options.
Urologiia. 2019;(4):105-111
pages 105-111 views

INFLUENCE OF RADICAL PROSTATECTOMY ON ORGASMIC FUNCTION

Veliev R.A., Veliev E.I., Sokolov E.A.

Abstract

This review is dedicated to orgasmic function which is one of the most intimate and crucial aspects of quality of life in patients who underwent radical prostatectomy for prostate cancer. The main risk factors that affect orgasmic function and recovery period after surgery are described.
Urologiia. 2019;(4):112-115
pages 112-115 views

RATIONALE OF EFFICIENCY AND SAFETY OF USING BETA-3 ADRENERGIC RECEPTOR AGONIST FOR TREATMENT OF OVERACTIVE BLADDER

Gadzhieva Z.K., Atamanova E.A.

Abstract

Currently, antimuscarinics are the most commonly used drugs for the treatment of overactive bladder (OAB). Improving quality of life and treatment satisfaction are key factors for adherence to therapy. Mirabegron, the first drug in the class of b3-adrenergic receptor agonists, is used as an alternative to antimuscarinic drugs in the treatment of OAB and it has proved efficacy and excellent safety profile. Observational studies can provide data on the efficiency of therapy in routine clinical practice, and real-life data indicate that the duration of treatment with mirabegron may be longer compared with that of antimuscarinic drugs. A prospective study (BELIEVE) has been the largest European study which evaluated quality of life, treatment satisfaction and adherence to therapy in patients with OAB who were prescribed mirabegron in routine clinical practice. The BELIEV E study has been approved by regulatory authorities in all participating countries based on local requirements. The primary end point was to evaluate the change in quality of life compared to baseline based on the OAB questionnaire. Secondary end points included evaluating treatment duration, patient satisfaction, use of health resources, and side effects. Subsequent observation was provided for 12 months with follow-up visits after 2-4 and 10-12 months of therapy. A total of 862 862 patients from 8 European countries were included in the study. 73.7% of patients were women, and the average age was 61.2 years; 47.7% of patients were older than 65 years. At the beginning of the study, 41.3% of patients preferred other types of treatment, 42.2% were treatment-naïve, 10.1% dropped out of the study, 6.4% received combination therapy. Storage symptoms and general quality of life improved from baseline to 2-4 and 10-12 months. There was a marked improvement in continence rate, increasing from 34.9% at the beginning to 43.7% after 10-12 months, and the use of pads decreased. Adherence to therapy was at a high level: 53.8% of patients continued taking mirabegron after 10-12 months. In general, no unexpected adverse events were observed, and they were consistent with the described safety profile of mirabegron. Patients receiving mirabegron reported a significant improvement in their quality of life and health status, while the level of adherence for the drug was 53.8% for 12 months. No unexpected safety problems were found, and side effects were consistent with previously described safety profile.
Urologiia. 2019;(4):116-121
pages 116-121 views

NON-GONOCOCCAL URETHRITIS IN MEN

Kim D.G., Gomberg M.A., Gushchin A.E., Zaycev A.V.

Abstract

This literature review is dedicated to urethritis which is one of the most common disorders of urogenital tract in men. The current views in its etiology as well as problems in diagnosis with the main being the frequent inability to isolate etiological factor of inflammation it the urethra are described. The analysis of literature suggests a possible role of bacteria, which are associated with bacterial vaginosis in women, in the development of the urethritis in men. However, the frequency of such urethritis and causative role of specific pathogens has not been studied yet. Meanwhile, the exact determination of the causes of inflammation has direct influence on the choice of appropriate etiologic treatment and can increase its efficiency.
Urologiia. 2019;(4):122-128
pages 122-128 views

EFFICIENCY OF PHOSPHODIESTERASE-5 INHIBITORS FOR TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND CONCOMITANT ERECTILE DYSFUNCTION

Kamalov A.A., Nizov A.N.

Abstract

Lower urinary tract symptoms (LUTS) in combination with benign prostatic hyperplasia and erectile dysfunction are more common than commonly thought. Unfortunately, urologists often don’t ask about concomitant erectile dysfunction in patients with irritative or obstructive symptoms, which leads to the progression of underline disease, a deterioration in the quality of sexual life, and, as a result, overall quality of life. The relevant studies of recent years dedicated to feasibility of using tadalafil 5 mg a day are analyzed in the article. In addition, the results of scientific work conducted on the Department of Urology and Andrology of Faculty of Fundamental Medicine of Lomonosov Moscow State University, whose aim was to study the efficiency of phosphodiesterase-5 inhibitors in patients with LUTS of varying severity in combination with other types of drugs, are presented. Tadalafil in a dose 5 mg leads to a decrease in the severity of LUTS, as confirmed by a decrease in the mean I-PSS score by 2.19 points in the presented studies. No significant changes were found in Qmax (р>0,05). We also proved in our work that phosphodiesterase-5 inhibitor can supplement any combined therapy for benign prostatic hyperplasia in the case of concomitant erectile dysfunction. Tadalafil in a dose 5 mg once a day can be recommended as monotherapy for patients with moderate LUTS caused by benign prostatic hyperplasia with concurrent erectile dysfunction, as an alternative to conventional treatment schemes.
Urologiia. 2019;(4):130-134
pages 130-134 views

NON-TRANSECTING ANASTOMOTIC URETHROPLASTY

Veliev E.I., Bogdanov A.B., Katibov M.I., Loran O.B.

Abstract

The review analyzes the results of using non-transecting anastomotic urethroplasty in men with urethral strictures. Identified 14 original studies using this technique: 13 foreign and 1 Russian. In total, this technique was applied in 704 patients. This technique was used in 85% of cases with bulbar urethral stricture, in 15% - with posterior stricture. The average length of the urethral stricture in all studies was less than 2 cm, except for two works, where the average stricture length was 2.3 cm and 3.9 cm, respectively. This technique is equally successfully applied in all etiological variants of urethral stricture. The incidence of postoperative complications in all studies using non-transecting anastomotic urethroplastyaveraged 13.7%. Postoperative complications were mostly mild and corresponded to G1 according to Clavien-Dindo classification.According to 10 out of 14 studies that evaluated the effect of surgical treatment on the occurrence of erectile dysfunction (ED), the incidence of ED de novo was on average 13.4%. The success of treatment with the use of non-transecting anastomotic urethroplastyaveraged 95% (82-100%) with a median postoperative follow-up of 27 months (6-64 months). In 4 out of 14 studies, an additional comparison was transecting versus non-transecting techniques. Non-transecting technique was not inferior to transecting technique by any criterion, but, on the contrary, exceeded it in a number of indicators, including the dynamics of sexual function after surgery.On the basis of available studies on the use of non-transecting anastomotic urethroplasty, this technique should be recognized as a highly efficient and reasonably safe method for treating short urethral strictures and recommended for widespread clinical use.
Urologiia. 2019;(4):135-140
pages 135-140 views

VITAPROST FORTE IN THE TREAMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: PATHOGENETIC BASICS AND CLINICAL RESULTS

Kuz’min I.V.

Abstract

The review is dedicated to the history of creation, biological effects and clinical use of prostatic peptides. Pathogenetic basics of using peptide drugs in prostatic disease are discussed. The results of clinical trials of efficiency of drug Vitaprost Forte in patients with benign prostatic hyperplasia are shown.
Urologiia. 2019;(4):141-147
pages 141-147 views

WHY ARE RECOMMENDATIONS ON THE STUDY OF EJACULATE NOT UPDATED?

Efremov E.A., Kasatonova E.V., Melnik Y.I., Nikushina A.A.

Abstract

In recent years, the quality of germinal cells has been recognized as the main factor determining reproductive potential. Standard sperm analysis is of limited value for predicting both the achievement of a pregnancy and the outcomes of assisted reproductive technologies, which raises the question of the additional significance of functional testing. Most current guidelines recommend to perform additional studies from a scientific point of view, recognizing their importance, but don’t include men in the basic diagnostic schemes. In this review, we try to discuss of the relevance of special sperm testing.
Urologiia. 2019;(4):148-154
pages 148-154 views

ROBOT-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY

Plekhanova O.A., Mono Pier S.O., Ostrovsky D.V., Martov A.G.

Abstract

Currently, partial nephrectomy as a nephron-sparing surgery is the standard treatment method of malignant kidney tumors stage T1 in the absence of contraindications. Robotic system is an intuitively convenient platform for performing partial nephrectomy of various degrees of complexity. The technique of robot-assisted laparoscopic partial nephrectomy continues to improve but is still not standardized. A description of surgical technique, results and complications of robot-assisted laparoscopic partial nephrectomy are presented in the article.
Urologiia. 2019;(4):155-162
pages 155-162 views

PSYHOSOMATIC ASPECTS OF DYSURIA IN WOMEN FROM THE PERSPECTIVE OF AN INTERDISCIPLINARY APPROACH

Dorozhenok I.Y., Gadgieva Z.K., Grigoryan V.A., Shvidkaya A.S.

Abstract

In clinical practice, urologist often has to treat women who have various forms of dysuria that do not have a pathomorphological substrate and manifest by various types of urinary disturbances and pathological sensations in the urinary tract. The relevance of this topic can be explained by the increasing prevalence of dysuria, its recurrent nature and insufficient efficiency of routine urotherapy, including the use of an extensive armamentarium of drugs and interventions, as well as by pronounced discomfort and a significant decrease in the quality of life and working capacity in the socially active adult patients. Despite a steady growing of interest in this problem, most researchers use a variety of questionnaires and evaluation methods and receive extremely unreliable data that do not contribute to an understanding of the serious psychourological problem of a particular patient with dysuria. In this article, such cases are discussed from the perspective of an interdisciplinary approach using the qualification apparatus of modern psychosomatic medicine and relying on the clinical experience of leading specialists in the field of urology and psychosomatics. The introduction of a comprehensive multidisciplinary approach into clinical practice will contribute to adequate referring, timely provision of specialized care, a reduction of medical costs and an increase in the quality of life in a large group of patients with dysuria.
Urologiia. 2019;(4):163-167
pages 163-167 views

THE ROLE OF HERBAL THERAPY, VITAMINS AND MICRONUTRIENTS FORMANAGEMENT OF MALE SEXUAL DYSFUNCTION AND MALE INFERTILITY

Kaputovskij A.A.

Abstract

The male sexual dysfunction and male infertility are worldwide medical and social problems. Herbal therapy and nutrients have used to treat it a long time. The aim of article is to define the components of dietary supplement Antiprost for management of male sexual dysfunction and male infertility according to evidence-based medicine.
Urologiia. 2019;(4):168-170
pages 168-170 views

RADIO WAVE METHODS OF TREATMENT IN UROGYNECOLOGY

Leshunov E.V., Martov A.G.

Abstract

Urinary incontinence (UI) represents one of the most common urogenital diseases in women. Considering a progressing of UI with ageing, there is a growing interest in minimally invasive treatment methods including monopolar radio wave remodeling. The results of the largest clinical trials and our own experience of using monopolar radio wave remodeling in treatment of stress UI in women of reproductive age are presented in the review.
Urologiia. 2019;(4):171-174
pages 171-174 views

MEDICAL TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA WITH 5A-REDUCTASE INHIBITORS

Spivak L.G., Platonova D.V., Yagudaev D.D.

Abstract

The results of studies comparing the therapy of benign prostatic hyperplasia with 5α-reductase inhibitors and α1-blockers are presented in the article. Benign prostatic hyperplasia is a common disease in older men. Pathogenetic treatment allows to block a progression of prostatic hyperplasia and is of greatest interest in the treatment of this disease. The obtained data reliably demonstrate the advantage and safety of longterm pathogenetic therapy with dutasteride compared with symptomatic tamsulosin monotherapy with regard to quality of life and subjective symptoms. In addition, pathogenetic therapy provides better results in preventing the progression of benign prostatic hyperplasia.
Urologiia. 2019;(4):175-179
pages 175-179 views

Lavrentyi Grigorievich Managadze (1945 - 2019)

- -.
Urologiia. 2019;(4):180-180
pages 180-180 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies